The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group

  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia, Critical, and Emergency Care Group
  4. Cochrane Back and Neck Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Common Mental Disorders Group
  10. Cochrane Consumers and Communication Group
  11. Cochrane Cystic Fibrosis and Genetic Disorders Group
  12. Cochrane Dementia and Cognitive Improvement Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
    1. About this group
    2. Reviews
      1. Acamprosate for alcohol dependenceReview
      2. Alcoholics Anonymous and other 12-step programmes for alcohol dependenceReview
      3. Alpha2-adrenergic agonists for the management of opioid withdrawalReview
      4. Anticonvulsants for alcohol dependenceReview
      5. Anticonvulsants for alcohol withdrawalReview
      6. Anticonvulsants for cocaine dependenceReview
      7. Antidepressants for cocaine dependence and problematic cocaine useReview
      8. Antipsychotic medications for cocaine dependenceReview
      9. Auricular acupuncture for cocaine dependenceReview
      10. Baclofen for alcohol withdrawalReview
      11. Benzodiazepines for alcohol withdrawalReview
      12. Brief interventions for heavy alcohol users admitted to general hospital wardsReview
      13. Brief school-based interventions and behavioural outcomes for substance-using adolescentsReview
      14. Buprenorphine for the management of opioid withdrawalReview
      15. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependenceReview
      16. Carbamazepine for cocaine dependenceReviewWithdrawn
      17. Case management for persons with substance use disordersReview
      18. Detoxification treatments for opiate dependent adolescentsReview
      19. Disulfiram for the treatment of cocaine dependenceReview
      20. Dopamine agonists for the treatment of cocaine dependenceReview
      21. Effectiveness of brief alcohol interventions in primary care populationsReview
      22. Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal SyndromeReviewOverview
      23. Efficacy of psychostimulant drugs for amphetamine abuse or dependenceReview
      24. Efficacy of Psychostimulant Drugs for Cocaine DependenceReview
      25. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapsesReview
      26. Heroin maintenance for chronic heroin-dependent individualsReview
      27. Inpatient versus other settings for detoxification for opioid dependenceReview
      28. Interventions for drug-using offenders in the courts, secure establishments and the community.ReviewWithdrawn
      29. Interventions for drug-using offenders with co-occurring mental illnessReview
      30. Interventions for female drug-using offendersReview
      31. Interventions for prevention of drug use by young people delivered in non-school settingsReview
      32. LAAM maintenance vs methadone maintenance for heroin dependenceReview
      33. Magnesium for alcohol withdrawalReview
      34. Maintenance agonist treatments for opiate-dependent pregnant womenReview
      35. Maintenance treatments for opiate -dependent adolescents Review
      36. Managed alcohol as a harm reduction intervention for alcohol addiction in populations at high risk for substance abuseReview
      37. Media campaigns for the prevention of illicit drug use in young peopleReview
      38. Mentoring adolescents to prevent drug and alcohol useReview
      39. Methadone at tapered doses for the management of opioid withdrawalReview
      40. Methadone maintenance at different dosages for opioid dependenceReview
      41. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependenceReview
      42. Motivational interviewing for alcohol misuse in young adultsReviewWithdrawn
      43. Motivational interviewing for substance abuseReview
      44. Opioid antagonists for alcohol dependenceReview
      45. Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawalReview
      46. Opioid antagonists with minimal sedation for opioid withdrawalReview
      47. Oral naltrexone maintenance treatment for opioid dependenceReview
      48. Oral substitution treatment of injecting opioid users for prevention of HIV infectionReview
      49. Pharmacologic Interventions for Pregnant Women Enrolled in Alcohol TreatmentReview
      50. Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settingsReviewWithdrawn
      51. Pharmacological interventions for drug-using offendersReview
      52. Pharmacological therapies for maintenance treatments of opium dependenceReview
      53. Pharmacological treatment for depression during opioid agonist treatment for opioid dependenceReview
      54. Pharmacotherapies for cannabis dependenceReview
      55. Primary prevention for alcohol misuse in young peopleReviewWithdrawn
      56. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxificationReview
      57. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependenceReview
      58. Psychosocial interventions for benzodiazepine harmful use, abuse or dependenceReview
      59. Psychosocial interventions for cocaine and psychostimulant amphetamines related disordersReviewWithdrawn
      60. Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventionsReview
      61. Psychosocial interventions for women enrolled in alcohol treatment during pregnancy.Review
      62. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug usersReview
      63. Psychosocial treatment for opiate abuse and dependenceReview
      64. Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settingsReviewWithdrawn
      65. Psychotropic analgesic nitrous oxide for alcoholic withdrawal statesReview
      66. QTc interval screening for cardiac risk in methadone treatment of opioid dependenceReview
      67. Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescentsReview
      68. Slow-release oral morphine as maintenance therapy for opioid dependenceReview
      69. Social norms information for alcohol misuse in university and college studentsReview
      70. Sustained-Release Naltrexone For Opioid DependenceReview
      71. Therapeutic communities for substance related disorderReview
      72. Treatment for amphetamine dependence and abuseReview
      73. Treatment for amphetamine psychosisReview
      74. Treatment for amphetamine withdrawalReview
      75. Treatment for inhalant dependence and abuseReview
      76. Treatment for Methaqualone dependence in adultsReview
      77. Universal family-based prevention programs for alcohol misuse in young peopleReview
      78. Universal multi-component prevention programs for alcohol misuse in young peopleReview
      79. Universal school-based prevention for illicit drug useReview
      80. Universal school-based prevention programs for alcohol misuse in young peopleReview
    3. Protocols
      1. Antidepressants for the treatment of depression in alcohol dependent individualsProtocol
      2. Auricular acupuncture for opiate dependence in substance misuse treatment programmesProtocol
      3. Brief alcohol questionnaires for identifying hazardous, harmful and dependent alcohol use in primary careProtocolDiagnostic
      4. Cognitive-behavioural treatment for amphetamine-type stimulants (ATS) use disordersProtocol
      5. Contingency management for substance use disordersProtocol
      6. Disulfiram for alcohol use disorderProtocol
      7. Dopaminergic antagonists for alcohol dependenceProtocol
      8. Effectiveness and safety of topiramate for drug dependentsProtocol
      9. Individual-, family-, and school-level interventions for preventing multiple risk behaviours relating to alcohol, tobacco and drug use in individuals aged 8 to 25 yearsProtocol
      10. Internet interventions for treatment of alcohol-related problemsProtocol
      11. Interventions to build resilience in children of problem drinkersProtocol
      12. Mindfulness-based interventions for substance use disordersProtocol
      13. Naltrexone for cocaine dependence treatmentProtocol
      14. Nicotine receptor partial agonists for alcohol dependenceProtocol
      15. Opioid agonist maintenance for opioid dependent patients in prisonProtocol
      16. Opioid agonist treatment for pharmaceutical opioid dependent peopleProtocol
      17. Personalised digital interventions for reducing hazardous and harmful alcohol consumption in community-dwelling populationsProtocol
      18. Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine usersProtocol
      19. Pharmacological therapies for management of opium withdrawalProtocol
      20. Psychological interventions for co-occurring depression and substance misuseProtocol
      21. Psychosocial and cultural interventions for reducing alcohol consumption during lactationProtocol
      22. Psychosocial interventions for cannabis abuse and/or dependence among persons with co-occurring cannabis use and psychotic disordersProtocol
      23. Psychosocial interventions for retention in drug abuse treatmentProtocol
      24. Psychosocial treatments for drugs and alcohol abusing adolescentsProtocol
      25. Telephone consultations for the management of alcohol-related disordersProtocol
      26. Traditional chinese medicine for opioid withdrawal syndromeProtocol
  15. Cochrane Effective Practice and Organisation of Care Group
  16. Cochrane ENT Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group
  21. Cochrane Gynaecology and Fertility Group
  22. Cochrane Haematological Malignancies Group
  23. Cochrane Heart Group
  24. Cochrane Hepato-Biliary Group
  25. Cochrane HIV/AIDS Group
  26. Cochrane Hypertension Group
  27. Cochrane IBD Group
  28. Cochrane Incontinence Group
  29. Cochrane Infectious Diseases Group
  30. Cochrane Injuries Group
  31. Cochrane Kidney and Transplant Group
  32. Cochrane Lung Cancer Group
  33. Cochrane Metabolic and Endocrine Disorders Group
  34. Cochrane Methodology Review Group
  35. Cochrane Movement Disorders Group
  36. Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group
  37. Cochrane Musculoskeletal Group
  38. Cochrane Neonatal Group
  39. Cochrane Neuromuscular Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Pregnancy and Childbirth Group
  43. Cochrane Public Health Group
  44. Cochrane Schizophrenia Group
  45. Cochrane Skin Group
  46. Cochrane STI Group
  47. Cochrane Stroke Group
  48. Cochrane Tobacco Addiction Group
  49. Cochrane Upper GI and Pancreatic Diseases Group
  50. Cochrane Urology Group
  51. Cochrane Vascular Group
  52. Cochrane Work Group
  53. Cochrane Wounds Group